Ignite Creation Date:
2025-12-24 @ 3:17 PM
Ignite Modification Date:
2025-12-26 @ 6:01 AM
Study NCT ID:
NCT00331292
Status:
TERMINATED
Last Update Posted:
2008-10-16
First Post:
2006-05-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Methodology Study To Look At Genes In Lung Cells And Tissue From Asthmatic Patients
Sponsor:
GlaxoSmithKline
Organization:
Study Overview
Official Title:
A Study to Identify a Transcriptomic Profile Indicative of Cycle AMP Pathway Activation in the Lung
Status:
TERMINATED
Status Verified Date:
2008-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary goal of this study is to identify a gene or panel of genes which are differentially expressed in lung cells and tissue from asthmatic patients following administration of Ipratropium bromide and eiTher nebulised Albuterol or saline. Each subject in this study will undergo two bronchoscopies.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: